Popular Diets Study
2016年11月22日 更新者:David S. Ludwig, MD, PhD、Boston Children's Hospital
Popular Diets, Metabolism, and CVD Risk
The aim of this study is to evaluate the effects of three dominant dietary patterns - conventional low-fat, low-glycemic index (GI) and very-low-carbohydrate - on energy metabolism and heart disease risk factors following weight loss in obese young adults in a feeding study
調査の概要
詳細な説明
For most of the last half century, reduction in fat intake has been the primary nutritional approach for the prevention and treatment of obesity and cardiovascular disease (CVD).
Over the last few years, very low carbohydrate (Atkins-type) diets have achieved great popularity, with publication of several studies suggesting greater weight loss and improvements in CVD risk factors over 3 to 6 months.
Recently, a third dietary approach focused on glycemic index (GI) has generated interest.
However, few studies have compared the effects of these diets on body weight regulation and risk for CVD.
The primary hypotheses of this study are that any diet that lowers the postprandial rise in blood glucose (very-low-carbohydrate or low-GI) will have beneficial effects on the physiological adaptations to weight loss and on some CVD risk factors.
However, other CVD risk factors will be adversely affected by a very-low-carbohydrate vs. a low-GI diet.
Preliminary data provide strong support for these hypotheses, by showing that resting energy expenditure declines less and CVD risk factors improve more with weight loss on a low-glycemic load diet compared to a conventional low-fat diet.
This application proposes a cross-over feeding design to study the effects of three diets following 12.5% weight loss in obese young adult subjects (n = 24, age 18 to 40 years).
The diets are: 1) conventional low-fat, with 60% carb, 20% fat, 20% protein; 2) low-GI with 40% carb, 40% fat, 20% protein; and 3) very-low-carbohydrate with 10% carb, 60% fat, 30% protein.
The primary outcome is resting energy expenditure (indirect calorimetry).
Secondary outcomes include total energy expenditure (doubly labeled water), thermic effect of food (indirect calorimetry), physical activity (accelerometry), insulin resistance and B-cell function (frequently-sampled OGTT), blood lipids, blood pressure and measures of systemic inflammation and coagulopathy.
This study should have major public health implications to the millions of Americans currently following diets to decrease body weight and risk for heart disease.
研究の種類
介入
入学 (実際)
24
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、02115
- Children's Hospital Boston
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
18年~40年 (大人)
健康ボランティアの受け入れ
はい
受講資格のある性別
全て
説明
Inclusion Criteria:
- BMI ≥ 27 kg/m2
- Willing and able to come to the GCRC 5 days per week to consume a supervised meal and pick-up food for all other meals
- Available for scheduled hospital admissions
- Willing to abstain from alcohol consumption for the duration of the study
- If female, regular menstrual cycles (defined as 26 to 30 days between cycles; no more than one day variation in the duration of menstrual flow)
Exclusion Criteria:
- Weight > 350 lbs
- Change in body weight (± 10%) over preceding year
- Taking any medications or dietary supplements that might affect body weight, appetite, or energy expenditure
- Smoking (1 cigarette in the last week)
- High levels of physical activity
- Currently following a special diet
- Abnormal laboratory screening tests
- Type 2 diabetes mellitus
- Allergies or aversions to foods on the study menu
- Previous diagnosis of an eating disorder or any other mental health disorder
- If female, pregnant in the past 12 months or planning to become pregnant during the study period
- If female, lactating in the preceding 12 months
- If taking birth control medication, change in medication in previous 3 months or plans to change medication during the study period
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:2
低脂肪食
|
Feeding protocol, all foods prepared in a metabolic kitchen
|
|
実験的:1
Low glycemic index diet
|
Feeding protocol, all foods prepared in a metabolic kitchen
|
|
アクティブコンパレータ:3
Very low carbohydrate diet
|
Feeding protocol, all foods prepared in a metabolic kitchen
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
resting energy expenditure using indirect calorimetry in the fasting state
時間枠:end of each dietary period
|
end of each dietary period
|
|
insulin resistance assessed by frequently-sampled oral glucose tolerance test
時間枠:end of each dietary period
|
end of each dietary period
|
|
thyroid function tests
時間枠:end of each dietary period
|
end of each dietary period
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
total energy expenditure using doubly labeled water methodology
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
thermic effect of food using indirect calorimetry
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
physical activity using accelerometry
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
serum lipids
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
plasminogen activator inhibitor-1
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
C-reactive protein
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
blood pressure
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
hunger/appetite
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
insulin 30 minutes after oral glucose (as an effect modifier)
時間枠:baseline
|
baseline
|
|
|
Core temperature
時間枠:End of each dietary period
|
End of each dietary period
|
|
|
secreted frizzle-related protein-4
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
heme-oxygenase
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
Irisin
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
fibroblast growth factor-21
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
chemerin
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
trimethylamine N-oxide
時間枠:fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
alanine aminotransferase
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
Uric acid
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
insulin
時間枠:fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
ghrelin
時間枠:fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
gastric inhibitory peptide
時間枠:fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
GLP1
時間枠:fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
PYY
時間枠:fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
Amylin
時間枠:fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
Leptin
時間枠:end of each dietary period
|
end of each dietary period
|
|
|
Metabolomic analysis
時間枠:end of each dietary period
|
Evaluate the effect of diet on metabolomic profile in plasma, with the aim of assessing dietary adherence and exploring diet-disease mechanisms
|
end of each dietary period
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
協力者
捜査官
- スタディディレクター:Cara B Ebbeling, PhD、Boston Children's Hospital
出版物と役立つリンク
研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。
一般刊行物
- Walsh CO, Ebbeling CB, Swain JF, Markowitz RL, Feldman HA, Ludwig DS. Effects of diet composition on postprandial energy availability during weight loss maintenance. PLoS One. 2013;8(3):e58172. doi: 10.1371/journal.pone.0058172. Epub 2013 Mar 6.
- Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012 Jun 27;307(24):2627-34. doi: 10.1001/jama.2012.6607.
- Hron BM, Ebbeling CB, Feldman HA, Ludwig DS. Hepatic, adipocyte, enteric and pancreatic hormones: response to dietary macronutrient composition and relationship with metabolism. Nutr Metab (Lond). 2017 Jul 5;14:44. doi: 10.1186/s12986-017-0198-y. eCollection 2017.
- Esko T, Hirschhorn JN, Feldman HA, Hsu YH, Deik AA, Clish CB, Ebbeling CB, Ludwig DS. Metabolomic profiles as reliable biomarkers of dietary composition. Am J Clin Nutr. 2017 Mar;105(3):547-554. doi: 10.3945/ajcn.116.144428. Epub 2017 Jan 11. Erratum In: Am J Clin Nutr. 2022 Feb 9;115(2):601.
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始
2006年4月1日
一次修了 (実際)
2010年6月1日
研究の完了 (実際)
2013年4月1日
試験登録日
最初に提出
2006年4月14日
QC基準を満たした最初の提出物
2006年4月14日
最初の投稿 (見積もり)
2006年4月18日
学習記録の更新
投稿された最後の更新 (見積もり)
2016年11月23日
QC基準を満たした最後の更新が送信されました
2016年11月22日
最終確認日
2016年11月1日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。